(NASDAQ: DWTX) Dogwood Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.8%.
Dogwood Therapeutics's earnings in 2025 is -$5,725,025.On average, 1 Wall Street analyst forecast DWTX's earnings for 2025 to be -$6,088,053, with the lowest DWTX earnings forecast at -$6,088,053, and the highest DWTX earnings forecast at -$6,088,053. On average, 1 Wall Street analyst forecast DWTX's earnings for 2026 to be -$2,531,138, with the lowest DWTX earnings forecast at -$2,531,138, and the highest DWTX earnings forecast at -$2,531,138.
In 2027, DWTX is forecast to generate $1,665,223 in earnings, with the lowest earnings forecast at $1,665,223 and the highest earnings forecast at $1,665,223.